Literature DB >> 26774978

Altered behaviour and cognitive function following combined deletion of Toll-like receptors 2 and 4 in mice.

Lay Khoon Too1, Iain S McGregor2, Alan G Baxter3, Nicholas H Hunt4.   

Abstract

Activation of the immune system due to infection or aging is increasingly linked to impaired neuropsychological function. Toll-like receptors 2 and 4 (TLR2, TLR4) are well-characterised for their role in inflammatory events, and their combined activation has been implicated in neurological diseases. We therefore determined whether TLR2 and TLR4 double gene knockout (GKO) mice showed modified behaviour and cognitive function during a 16-day test sequence that employed the automated IntelliCage test system. The IntelliCage features a home cage environment in which groups of mice live and where water reward is gained through performing various tasks centred on drinking stations in each corner of the apparatus. All mice were tested twice, one month apart (the first sequence termed "R1"and the second "R2"). There were fewer corner visits and nosepokes in TLR2/4 GKO compared to wild-type mice during early exploration in R1, suggesting elevated neophobia in GKO mice. Reduced exploration persisted over subsequent test modules during the dark phase. TLR2/4 GKO mice also displayed increased corner visits during drinking sessions compared to non-drinking sessions, but this was not associated with increased drinking. In subsequent, more complex test modules, TLR2/4 GKO mice had unimpaired spatial learning, but showed markedly poorer performance in a visual discrimination reversal task compared to wild-type mice. These results indicated subtle impairments in behaviour and cognitive functions due to double deficiency in TLR2 and TLR4. These finding are highly relevant to understanding the combined actions of TLR2 and TLR4 on neurological status in a range of different disease conditions. Crown
Copyright © 2016. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Behavior; Cognition; Innate immune system; IntelliCage; Toll-like receptor

Mesh:

Substances:

Year:  2016        PMID: 26774978     DOI: 10.1016/j.bbr.2016.01.024

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  6 in total

Review 1.  Visceral Inflammation and Immune Activation Stress the Brain.

Authors:  Peter Holzer; Aitak Farzi; Ahmed M Hassan; Geraldine Zenz; Angela Jačan; Florian Reichmann
Journal:  Front Immunol       Date:  2017-11-22       Impact factor: 7.561

2.  Double deficiency of toll-like receptors 2 and 4 alters long-term neurological sequelae in mice cured of pneumococcal meningitis.

Authors:  Lay Khoon Too; Belinda Yau; Alan G Baxter; Iain S McGregor; Nicholas H Hunt
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379

Review 3.  The IntelliCage System: A Review of Its Utility as a Novel Behavioral Platform for a Rodent Model of Substance Use Disorder.

Authors:  Ismail Nurul Iman; Nurul Aiman Mohd Yusof; Ummi Nasrah Talib; Nur Aimi Zawami Ahmad; Anwar Norazit; Jaya Kumar; Muhammad Zulfadli Mehat; Nanthini Jayabalan; Sangu Muthuraju; Marzena Stefaniuk; Leszek Kaczmarek; Mustapha Muzaimi
Journal:  Front Behav Neurosci       Date:  2021-06-04       Impact factor: 3.558

Review 4.  Toll-like receptors in the pathogenesis of autoimmune diseases: recent and emerging translational developments.

Authors:  Laura Duffy; Steven C O'Reilly
Journal:  Immunotargets Ther       Date:  2016-08-22

Review 5.  Cross Talk: The Microbiota and Neurodevelopmental Disorders.

Authors:  John R Kelly; Chiara Minuto; John F Cryan; Gerard Clarke; Timothy G Dinan
Journal:  Front Neurosci       Date:  2017-09-15       Impact factor: 4.677

6.  Genomic deletion of TLR2 induces aggravated white matter damage and deteriorated neurobehavioral functions in mouse models of Alzheimer's disease.

Authors:  Chao Zhou; Xiaoyu Sun; Yuting Hu; Jiaxing Song; Shuyu Dong; Delian Kong; Yuqiao Wang; Xiaodong Hua; Jingjing Han; Yan Zhou; Guoliang Jin; Xinxin Yang; Hongjuan Shi; Zuohui Zhang; Fang Hua
Journal:  Aging (Albany NY)       Date:  2019-09-11       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.